4//SEC Filing
Chadha Deepak 4
Accession 0001062993-21-002791
CIK 0000819050other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:53 PM ET
Size
8.3 KB
Accession
0001062993-21-002791
Insider Transaction Report
Form 4
Chadha Deepak
Chief Research & Dev. Officer
Transactions
- Tax Payment
Common Stock
2021-03-16$1.14/sh−8,750$9,975→ 62,967 total - Exercise/Conversion
Common Stock
2021-03-16+25,000→ 71,717 total - Exercise/Conversion
Restricted Stock Units
2021-03-16−25,000→ 0 total→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
- [F3]These RSUs vested in full on March 16, 2021.
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001784380
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:53 PM ET
- Size
- 8.3 KB